QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=369D0FFBC2D87636BB1B0994D6332FBD;jsessionid=2C26338D5DC8827803FB6EF110BAA954;jsessionid=3A36BEE91D16E3FB0977B7BD83A3D763;jsessionid=36AD311474EEC49AAFB94416A4134286;jsessionid=3D00110BD89EE8D12A11A90552B5091E;jsessionid=D458F4C020940DD66BBEC7E113D06C04;jsessionid=9C4884C76A5D541F9F20AD54653D9E56 (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=369D0FFBC2D87636BB1B0994D6332FBD;jsessionid=2C26338D5DC8827803FB6EF110BAA954;jsessionid=3A36BEE91D16E3FB0977B7BD83A3D763;jsessionid=36AD311474EEC49AAFB94416A4134286;jsessionid=3D00110BD89EE8D12A11A90552B5091E;jsessionid=D458F4C020940DD66BBEC7E113D06C04;jsessionid=9C4884C76A5D541F9F20AD54653D9E56